Lupus Research Alliance News
Third Vaccine Shield Against COVID-19 Rolling Out March 1, 2021

March 1, 2021 Americans gained a third weapon against COVID-19 this weekend with the availability of a third vaccine. On February 27, 2021, the U.S. Food and Drug Administration granted Emergency Use Authorization to the new vaccine from Janssen Pharmaceutical Companies of Johnson & Johnson to prevent COVID-19 in adults age 18 and older. The […] READ MORE

Join LRA March 11 to Learn What’s New in Lupus Nephritis

What’s New in Lupus Nephritis? A Research & Treatment Update A Learn from Lupus Webcast Lupus nephritis is a common and dangerous complication of lupus marked by inflammation that can lead to damage and possible failure of the kidney. While up to half of people with lupus develop lupus nephritis, a new survey by the Lupus […] READ MORE

Lupus Gains a Strong Advocate in Physician/Researcher Dr. Ashira Blazer

February 25, 2021 Dr. Ashira Blazer is literally a rising star. This year, she won the 40 Under 40 Leaders in Minority Health Award sponsored by the National Minority Quality Forum, an organization with which the Lupus Research Alliance works closely.  But what makes her a winner? And why is the LRA celebrating her during […] READ MORE

New COVID-19 Vaccine Clinical Guidance and Planned Research

Important news for people with lupus as COVID-19 vaccines are on everyone’s minds.  The foremost authority in rheumatologic diseases, the American College of Rheumatology (ACR) recently issued the COVID-19 Vaccine Clinical Guidance. Developed by a panel of rheumatologists, specialists in infectious disease and public health experts, the Guidance aims to help healthcare providers make decisions with their […] READ MORE

Study Links Endometriosis and Lupus

February 24, 2021 A new study published in Scientific Reports links endometriosis to an increased risk for systemic lupus erythematosus.  Conducted based on the National Health Insurance Research Database in Taiwan, the study showed that women with endometriosis between 30 and 45, used non-steroidal inflammatory drug users or did not use hormonal medications. Endometriosis happens when […] READ MORE

JDRF, Lupus Research Alliance, and National Multiple Sclerosis Society Join Forces to Decode Common Mechanisms of Autoimmune Diseases

First Joint Common Mechanisms Grants Announced NEW YORK, NY, February 24, 2021 – JDRF International, the Lupus Research Alliance and the National Multiple Sclerosis Society joined forces to accelerate research and discovery in autoimmunity and are proud to announce the recipients of their first joint grants. Called Decoding Immune-Mediated Diseases – Novel Approaches for Therapeutic […] READ MORE

Virtual Events Were Real-ly Successful!

While the pandemic made it impossible for the LRA to hold in person fundraising events, we still achieved great success thanks to the determination of our supporters to fund crucial lupus research. Likewise, our “virtual gala” – bolstered by superstars like Lady Gaga and Selena Gomez – raised an astounding $3.3 million and was attended […] READ MORE

Catalyzing Research

First Lupus Nephritis Drug Approved In December of 2020, lupus research attained another major milestone-one which stemmed from a critical investigation funded by our organization. Now, with the FDA’s approval, belimumab (Benlysta®) can be used as a therapeutic for lupus nephritis. “An effective treatment developed specifically for lupus nephritis has been desperately needed,” commented Lupus […] READ MORE

Unraveling the Complexity of Lupus

New Strategic Plan Holds Great Promise The LRA has one purpose-to work on multiple fronts to improve the health of everyone with lupus through the power of science. Even with the unprecedented challenges of 2020, the LRA not only has remained true to this mission-the organization took a bold step forward with the launch of […] READ MORE

Learn and connect with our community!